Investigation of the use of nanotechnology in targeted drug delivery for cancer treatment.

Thesis Abstract

Abstract
The application of nanotechnology in medicine has shown great promise in improving targeted drug delivery for cancer treatment. This thesis investigates the potential of utilizing nanotechnology to enhance the efficacy and reduce the side effects of cancer treatments. The study explores various nanocarriers, such as liposomes, nanoparticles, and micelles, as delivery systems for anticancer drugs. By encapsulating the drugs within these nanocarriers, targeted delivery to cancer cells can be achieved, minimizing damage to healthy tissues. The first chapter provides an introduction to the topic, highlighting the background of the study, the problem statement, objectives, limitations, scope, significance, structure of the thesis, and definitions of key terms. The subsequent chapter presents a comprehensive literature review on nanotechnology in cancer treatment, covering areas such as the challenges of conventional drug delivery, the advantages of nanocarriers, recent advancements, and future prospects. Chapter three details the research methodology employed in this study, including the selection of materials, experimental procedures, data collection methods, and statistical analysis. The research methodology aims to investigate the effectiveness of various nanocarriers in delivering anticancer drugs to specific targets. Chapter four presents a detailed discussion of the findings, analyzing the performance of different nanocarriers in drug delivery, comparing their effectiveness in targeting cancer cells, and evaluating their potential for clinical applications. The chapter also discusses the implications of the findings for future research and clinical practice. Finally, chapter five provides a summary of the thesis, highlighting the key findings, discussing the implications for cancer treatment, and offering recommendations for future research directions. The study concludes that nanotechnology holds great promise in revolutionizing targeted drug delivery for cancer treatment, offering new opportunities for more effective and personalized therapies. In conclusion, this thesis contributes to the growing body of knowledge on the use of nanotechnology in cancer treatment and provides valuable insights into the potential applications of nanocarriers for targeted drug delivery. The findings of this study have important implications for improving cancer treatment outcomes and enhancing patient quality of life.